Serum bilirubin may serve as a marker for increased heme oxygenase activity and inducibility in tissues--a rationale for the versatile health protection associated with elevated plasma bilirubin

Medical Hypotheses
Mark F McCarty

Abstract

Unconjugated bilirubin functions intracellularly as a potent inhibitor of NADPH oxidase complexes, and albumin-bound bilirubin contributes significantly to the oxidant scavenging activity of plasma. So it is not surprising that serum levels of bilirubin have been found to correlate inversely with risk for vascular diseases and a host of other disorders. Nonetheless, recent Mendelian randomization analyses reveal that individuals who carry low expression alleles of the hepatic bilirubin conjugating enzyme UGT1A1, and hence have somewhat elevated levels of plasma bilirubin throughout life, are not at decreased risk for vascular disorders. This likely reflects the fact that, in most people, plasma levels of unconjugated, unbound bilirubin--the fraction of bilirubin capable of fluxing back into cells--are so low (near 1 nM) that they can exert only a trivial antioxidant influence on cells. In light of these findings, it is reasonable to propose that the inverse correlation of plasma bilirubin and disease risks noted in many studies often reflect the fact that elevated plasma bilirubin can serve as a marker for an increased propensity to generate bilirubin within cells. Consistent with this view, high expression alleles of the major...Continue Reading

References

Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R StockerB N Ames
Nov 23, 2001·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·M ExnerO Wagner
Jun 25, 2002·International Journal of Clinical Pharmacology and Therapeutics·S K RauchschwalbeJ Kuhlmann
Aug 17, 2002·Thrombosis Research·Martin SchillingerErich Minar
Mar 19, 2004·Journal of the American College of Cardiology·Martin SchillingerOswald Wagner
Jun 3, 2004·Pediatrics·Thomas W Sedlak, Solomon H Snyder
Jul 1, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hong Pyo KimAugustine M K Choi
Sep 29, 2004·Free Radical Biology & Medicine·Markus ExnerMartin Schillinger
Nov 13, 2004·American Journal of Physiology. Renal Physiology·Axel PfluegerKarl A Nath
Jan 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Atsunori NakaoNoriko Murase
Apr 2, 2005·Inflammatory Bowel Diseases·Pascal O BerberatFritz H Bach
Aug 10, 2005·Circulation·Robert OllingerFritz H Bach
Sep 1, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sophie LanoneJorge Boczkowski
Oct 29, 2005·Endocrinology·Hongjun WangFritz H Bach
Nov 30, 2005·European Journal of Clinical Investigation·P DickM Exner
Feb 4, 2006·British Journal of Neurosurgery·L MorganN Kitchen
Aug 23, 2006·Molecular and Cellular Biology·Jianyong ZhangMasayuki Yamamoto
Jan 25, 2007·Cell Cycle·Robert OllingerFritz H Bach
Mar 14, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Karl A NathZvonimir S Katusic
Sep 27, 2007·JAMA : the Journal of the American Medical Association·Toyoshi InoguchiTomomi Yamada
Oct 9, 2007·Antioxidants & Redox Signaling·Robert OllingerFritz H Bach
Dec 27, 2007·Journal of Medicinal Food·Mark F McCarty
Nov 13, 2008·Antioxidants & Redox Signaling·Masuko Ushio-Fukai
Sep 17, 2009·Current Pharmaceutical Design·Libor Vítek, J Donald Ostrow
Dec 22, 2009·Cell Transplantation·Fredy RocutsHongjun Wang
Apr 13, 2010·Antioxidants & Redox Signaling·Ying ZhangJoan C Krepinsky
Feb 18, 2011·JAMA : the Journal of the American Medical Association·Laura J HorsfallIrene Petersen
Mar 31, 2011·The Journal of Nutritional Biochemistry·Yuanyuan ZhengBernhard Hennig

❮ Previous
Next ❯

Citations

Feb 19, 2015·Nutrients·Lynnda J N van Tienhoven-Wind, Robin P F Dullaart
Jan 8, 2016·Hormone Molecular Biology and Clinical Investigation·Mark F McCarty
Jun 12, 2016·Cell Biochemistry and Biophysics·Marcello MocciaCarmine Vitale
Mar 6, 2015·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M MocciaC Vitale
Mar 22, 2016·European Journal of Clinical Investigation·Jorien Werumeus BuningRobin P F Dullaart
Aug 26, 2014·Clinical Biochemistry·Robin P F DullaartJoop D Lefrandt
Jun 19, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Claudia StoltAntje Bast
Apr 13, 2021·Journal of Global Antimicrobial Resistance·Fangyi LiZhijie He

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.